HLA-C and type 1 diabetes mellitus: Approximately 80% of participants classified with “high genetic risk” (T1D GRS ≥ 5) would also be classified as “high genetic risk” by restricting the T1D GRS to using only those SNPs in the MHC (Fig. 3).